U.S. Markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
317.93-0.25 (-0.08%)
At close: 4:00PM EDT

317.93 0.00 (0.00%)
After hours: 5:29PM EDT

People also watch
CELGREGNGILDAMGNALXN
Full screen
Previous Close318.18
Open318.43
Bid317.25 x 200
Ask320.00 x 100
Day's Range316.55 - 319.41
52 Week Range244.28 - 330.00
Volume573,724
Avg. Volume1,379,625
Market Cap67.22B
Beta0.50
PE Ratio (TTM)20.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Profit From the Biogen Inc (BIIB) Stock Dip!
    InvestorPlace8 hours ago

    Profit From the Biogen Inc (BIIB) Stock Dip!

    Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. Clearly, this is a momentum stock, so it will never give us a clear signal for entry. More often than not, traders tend to overshoot with the price action of momentum stocks.

  • Apple Leads 7 Top Stocks Holding In Buy Range
    Investor's Business Daily11 hours ago

    Apple Leads 7 Top Stocks Holding In Buy Range

    With the market grinding higher, some breakouts struggle. But Apple, Microsoft, Biogen, Alexion Pharmaceuticals, Wynn Resorts and Electronic Arts are holding in buy zones after breaking out several days or weeks ago.

  • Barrons.comyesterday

    Gilead Sciences: Is The Kite Deal Too Little, Too Late?

    Last month, Gilead Sciences (GILD) made big news when it announced the acquisition of Kite Pharma (KITE). For the most part, analysts were bullish on the deal, with the noted exception being Leerink's Geoffrey Porges and Bradley Canino. The pair penned a note late last month explaining why they were not excited by Gilead’s latest purchase.